112 related articles for article (PubMed ID: 12538026)
1. Structure-activity relationships of 6-fluoroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Obara F; Hayashi H
Bioorg Med Chem; 2003 Feb; 11(4):609-16. PubMed ID: 12538026
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 6-nitro-7-(1-piperazino)quinazolines: dual-acting compounds with inhibitory activities toward both tumor necrosis factor-alpha (TNF-alpha) production and T cell proliferation.
Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Aoki M; Negishi T; Hayashi H
Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1109-12. PubMed ID: 12951460
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of quinazoline derivatives: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
Tobe M; Isobe Y; Tomizawa H; Matsumoto M; Obara F; Nagasaki T; Hayashi H
Bioorg Med Chem Lett; 2001 Feb; 11(4):545-8. PubMed ID: 11229767
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of 6-nitroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.
Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Obara F; Matsumoto M; Hayashi H
Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1073-80. PubMed ID: 12192139
[TBL] [Abstract][Full Text] [Related]
5. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation.
Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Takahashi H; Fukazawa T; Hayashi H
Bioorg Med Chem; 2003 Feb; 11(3):383-91. PubMed ID: 12517433
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular docking of quinazoline-4(1H)-one derivatives as anti-inflammatory and analgesic agents.
Mohamed MS; Kamel MM; Kassem EM; Abotaleb N; Khedr M; Ahmed MF
Acta Pol Pharm; 2011; 68(5):665-75. PubMed ID: 21928711
[TBL] [Abstract][Full Text] [Related]
7. A new three-component reaction: green synthesis of novel isoindolo[2,1-a]quinazoline derivatives as potent inhibitors of TNF-α.
Kumar KS; Kumar PM; Kumar KA; Sreenivasulu M; Jafar AA; Rambabu D; Krishna GR; Reddy CM; Kapavarapu R; Shivakumar K; Priya KK; Parsa KV; Pal M
Chem Commun (Camb); 2011 May; 47(17):5010-2. PubMed ID: 21445417
[TBL] [Abstract][Full Text] [Related]
8. A novel structural class of potent inhibitors of NF-kappa B activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives.
Tobe M; Isobe Y; Tomizawa H; Nagasaki T; Takahashi H; Hayashi H
Bioorg Med Chem; 2003 Sep; 11(18):3869-78. PubMed ID: 12927847
[TBL] [Abstract][Full Text] [Related]
9. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological screening of 1,3,4-thiadiazino[2,3-b]quinazoline derivatives.
Santagati A; Modica M; Santagati M; Cutuli VM; Mangano NG; Caruso A
Pharmazie; 2000 Oct; 55(10):737-40. PubMed ID: 11082833
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some new quinazolines and quinoxalines of potential antiinflammatory activity.
el-Bendary ER; el-Ashmawy MB; Barghash AM; Shehata IA; el-Kerdawy MM
Boll Chim Farm; 1996 Dec; 135(11):617-20. PubMed ID: 9066171
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and anti-arthritic effects of methanol extract of the stem bark of Boswellia dalzielii Hutch (Burseraceae) in rats.
Mbiantcha M; Almas J; Atsamo AD; Ateufack G; Shabana SU; Bomba Tatsinkou DF; Yousseu Nana W; Nida D
Inflammopharmacology; 2018 Dec; 26(6):1383-1398. PubMed ID: 29948494
[TBL] [Abstract][Full Text] [Related]
14. Changes in T and B lymphocyte proliferative responses in adjuvant-arthritic rats: antagonism by indomethacin.
Seng GF; Benensohn J; Bayer BM
Eur J Pharmacol; 1990 Mar; 178(3):267-73. PubMed ID: 2340860
[TBL] [Abstract][Full Text] [Related]
15. 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.
Das J; Chen P; Norris D; Padmanabha R; Lin J; Moquin RV; Shen Z; Cook LS; Doweyko AM; Pitt S; Pang S; Shen DR; Fang Q; de Fex HF; McIntyre KW; Shuster DJ; Gillooly KM; Behnia K; Schieven GL; Wityak J; Barrish JC
J Med Chem; 2006 Nov; 49(23):6819-32. PubMed ID: 17154512
[TBL] [Abstract][Full Text] [Related]
16. Substituted xanthines, pteridinediones, and related compounds as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha.
Cottam HB; Shih H; Tehrani LR; Wasson DB; Carson DA
J Med Chem; 1996 Jan; 39(1):2-9. PubMed ID: 8568809
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevent to rheumatoid arthritis.
Cho JY; Park JS; Baik KU; Lee JG; Kim HP; Yoo ES; Park MH
Pharmacol Res; 2004 May; 49(5):423-31. PubMed ID: 14998551
[TBL] [Abstract][Full Text] [Related]
18. 2H-pyrano[2,3-f]quinazoline derivatives with platelet antiaggregating and other activities.
Longobardi M; Mariani E; Bargagna A; Schenone P; Budetta S; Losasso C; Cenicola ML; Donnoli D; De Santis D; Marmo E
Farmaco; 1991 Jan; 46(1):99-110. PubMed ID: 2054045
[TBL] [Abstract][Full Text] [Related]
19. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis.
Cicala C; Ianaro A; Fiorucci S; Calignano A; Bucci M; Gerli R; Santucci L; Wallace JL; Cirino G
Br J Pharmacol; 2000 Jul; 130(6):1399-405. PubMed ID: 10903982
[TBL] [Abstract][Full Text] [Related]
20. Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.
Baba A; Kawamura N; Makino H; Ohta Y; Taketomi S; Sohda T
J Med Chem; 1996 Dec; 39(26):5176-82. PubMed ID: 8978845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
